Navigation Links
Genoptix Announces Participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference
Date:5/6/2009

CARLSBAD, Calif., May 6 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the Company's participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference at The New York Palace Hotel in New York City on May 12 - 14, 2009.

Sam Riccitelli, EVP and COO of Genoptix, will present at the conference on Tuesday, May 12, 2009 beginning at approximately 8:00 a.m. EDT. He will provide an overview of the Company's specialized diagnostic laboratory services business, growth strategies and financial performance.

The presentation is expected to last approximately 30 minutes, including an audience Q&A session, which will be web cast live and made accessible through the "Investors" section of the Genoptix website at www.genoptix.com. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. Founded in 1999, Genoptix completed its initial public offering in November 2007 and is headquartered in Carlsbad, California. For more information, please visit www.genoptix.com.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements.


'/>"/>
SOURCE Genoptix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Reports Strong Growth for the First Quarter of 2009
2. Genoptix, Inc. to Announce First Quarter 2009 Financial Results
3. Genoptix Announces Participation at the Cowen and Company 29th Annual Health Care Conference
4. Genoptix Announces Participation at Barclays Capital Global Healthcare Conference
5. Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009
6. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
7. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
8. Genoptix Announces the Addition of New Members to Board of Directors
9. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
10. Genoptix Reports Strong Financial Results for First Quarter 2008
11. Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... Hotze ... industry, announces Chris Brandl as its New Guest Director. , Brandl is ... corporations throughout his career. He began his professional career at Omnium Worldwide, now ...
(Date:2/27/2017)... ... 2017 , ... The threat of nuclear warfare has long plagued this world. ... the underground testing of nuclear weapons. Years later, when her co-workers began dying, Dot ... War Nuclear Testing,” Clayton exposes the critical decisions made by agencies involved in the ...
(Date:2/27/2017)... Shenzhen, China (PRWEB) , ... February 26, 2017 , ... ... , This pioneer sound and video system brings songs, movies, TV shows and much ... 3D sound offers clear, high-definition sound. An immersive view of 1280 x 720 provides ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... hair transplantation therapy, is proud to announce a new informational post on robotic ... procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit Transplantation (FUT) can ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... for entries to the 7th Edition of International Social Design Awards. , ... Professionals, Product Designers, System Designers, Governments and Institutions worldwide with realized projects and ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 27, 2017 Mederi Therapeutics today announced ... representing 2468 patients who received  Stretta Therapy  to ... " Systematic Review and Meta-Analysis of Controlled and ... Treatment of Gastroesophageal Reflux Disease ", was published in ... Fass , MD, head of the Esophageal and ...
(Date:2/27/2017)... , Feb. 27, 2017   Vitasome ® ... nutritional supplements using its groundbreaking new liposome technology. Whereas ... of potency through digestion per Physician,s Desk Reference ... the problem of nutritional waste and are scientifically formulated ... digestive processes Improve bioavailability with a ...
(Date:2/27/2017)... A recent research report published by Grand View Research, Inc. ... reach a value of $55.8 billion by 2025. Earlier in 2016, ... legalized marijuana for medical uses. In 2016, states such as ... North Dakota , Ohio and ... medical applications such as chemotherapies and pain management. The growing number ...
Breaking Medicine Technology: